Analysis SunLink Health Systems Inc (SSY)
6/5/2024
Analysis of SunLink Health Systems Inc (SSY)
SunLink Health Systems Inc (SSY) is showing some interesting price movements and technical indicators based on the provided data.1. **Price Movement**: The closing prices have been fluctuating between 0.59 and 0.71 over the past few days, showing some volatility in the stock.
2. **Relative Strength Index (RSI)**: The RSI values have been fluctuating around the 30-70 range, indicating some oscillation in the stock's momentum. The latest RSI value of 69.11 suggests that the stock may be slightly overbought.
3. **Moving Average Convergence Divergence (MACD)**: The MACD line has been hovering around the signal line, with the MACD histogram showing small fluctuations around the zero line. This indicates a lack of strong trend in the stock's price movement.
4. **Moving Averages (MA)**: The stock's closing prices have been close to the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, indicating a relatively stable trend.
In conclusion, SunLink Health Systems Inc (SSY) is currently experiencing some volatility in its price movements with no clear trend based on the technical indicators. Traders and investors may need to closely monitor the stock for any potential breakout or trend reversal.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results for January 31, 2025, were released after hours. The results for October 31, 2024, were not provided at the time. The results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a relatively high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and insider and institutional ownership percentages. The company's stock price summary provides information on beta, moving averages, and the range of the stock price over the past year.
Valuation metrics show metrics such as P/E ratio, PEG ratio, price to book, price to sales, and market capitalization. The enterprise value and various ratios provide insights into the company's valuation.
Lastly, dividends and splits information includes details on dividend rates, payout ratio, dividend dates, and historical splits. The company offers a dividend yield and has a history of dividend payments and stock splits.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential decrease in profit margins.
3. The company's gross profit has fluctuated over the years, reaching its peak in 2023 at $169.1 billion.
4. Operating income has shown an upward trend, with the company generating $114.3 billion in 2023 compared to $66.3 billion in 2020.
5. Net income has also been increasing annually, reaching $97 billion in 2023 from $57.4 billion in 2020.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to maintain a stable number of outstanding shares, indicating no significant dilution of shares.
8. Overall, the financial performance of the company in terms of revenue and income has been positive, showing growth and profitability.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been increasing, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been steadily increasing its shareholders' equity, indicating a positive trend in the company's financial health.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This forecast suggests a slight improvement from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, with a sales growth of 2% compared to the same period last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average estimate increases to $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average estimate for total revenue is $357,772,000,000, showing a 1% growth compared to the previous year. The number of analysts providing estimates increases to 38.
In the following fiscal year ending on September 30, 2025, the average estimate for total revenue is projected to be $380,772,000,000, indicating a more significant growth of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly more optimistic outlook for the next fiscal year.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly strong growth rate projected for the next year and the next 5 years. This indicates positive sentiment and potential opportunities for investors in the company.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these figures, it can be observed that the current price of $192.25 is below both the median and average forecasted prices. The analysts' predictions suggest a potential increase in the price of the security, with a high estimate of $275. Investors may consider this information when making decisions about buying or selling the security.
MACD of SSY
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
